Ypsomed will establish its first manufacturing facility in the United States. The company has selected Holly Springs in Wake County, North Carolina, as the location and will invest around CHF 200 million in a first phase. This is another milestone in Ypsomed’s global growth strategy, bringing the company closer to its customers and enabling it to serve local markets directly. From end of 2027 onwards, the new site in Holly Springs will supply products for the U.S. market.
With more than 650 life sciences operations in North Carolina’s Research Triangle alone, every stage of the biopharmaceutical supply chain is represented from research and product development to device manufacturing, fill/finish, and delivery. Wake County brings together research, talent and community to scale the industry and move ideas to market.
This announcement brings an expansion in the life science offerings in Holly Springs, diversifying the types of companies located here, said Town of Holly Springs Mayor Sean Mayefskie.
Everyone knows about the global biotech leaders who call Holly Springs home, and Ypsomed will provide needed supplies to contribute to the creation of life-saving medications these companies will produce right here in Holly Springs.